Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ben Hendrix
RBC

Ben Hendrix

RBC Capital
Wall Street Analyst
★★★☆☆
#978
on 13Foresight · ranked by our own returns
58%
Success Rate
+4.6%
Average Return
58 of 100 calls profitable · +24.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 58% of Ben Hendrix's ratings turned a profit when each position was held for 1 year — averaging +4.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

146 Buy 50 Hold 0 Sell
Ben's Stock Coverage 29 ratings · 2026-11-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
HCA
HCA Healthcare
 Oct 29, 2026 BUY Strong Buy
-11.8% avg upside
37 analysts
$521.00
10.11% Upside
 +4.1% ·
MAX
MediaAlpha
 Oct 28, 2026 BUY Strong Buy
+19.8% avg upside
14 analysts
$17.00
15.30% Upside
 +24.7% ·
CHE
Chemed
 Oct 28, 2026 HOLD Strong Buy
+14.2% avg upside
6 analysts
$585.00
9.32% Upside
 +3.2% ·
SGRY
Surgery Partners
 Oct 26, 2026 HOLD Buy
+8.0% avg upside
18 analysts
$23.50
1.19% Upside
 +14.2% ·
MOH
Molina Healthcare
 Oct 22, 2026 HOLD Hold
+16.5% avg upside
26 analysts
$222.00
8.36% Upside
 -4.5% ·
ELV
Elevance Health
 Oct 21, 2026 HOLD Strong Buy
+10.7% avg upside
33 analysts
$455.00
8.29% Upside
 -2.9% ·
UNH
UnitedHealth
 Oct 19, 2026 BUY Strong Buy
+12.6% avg upside
36 analysts
$498.00
22.43% Upside
 -0.4% ·
BKD
Brookdale Senior Living
 Oct 08, 2026 BUY Strong Buy
+38.5% avg upside
11 analysts
$17.00
63.63% Upside
 -16.7% ·
CI
Cigna
 Oct 07, 2026 BUY Strong Buy
+15.7% avg upside
30 analysts
$337.00
13.01% Upside
 +8.2% ·
CNC
Centene
 Oct 07, 2026 HOLD Buy
+7.4% avg upside
29 analysts
$71.00
3.72% Upside
 +6.2% ·
CYH
Community Health
 Oct 07, 2026 BUY Sell
+66.3% avg upside
20 analysts
$4.00
66.63% Upside
 -20.2% ·
CVS
CVS Health
 Oct 07, 2026 BUY Strong Buy
+19.5% avg upside
39 analysts
$113.00
25.14% Upside
 +2.8% ·
HUM
Humana
 Oct 07, 2026 HOLD Strong Buy
+5.9% avg upside
34 analysts
$415.00
0.10% Upside
 +11.8% ·
THC
Tenet Healthcare
 Oct 07, 2026 BUY Strong Buy
-9.6% avg upside
29 analysts
$283.00
3.59% Upside
 +11.7% ·
UHS
Universal Health
 Oct 07, 2026 HOLD Buy
+8.4% avg upside
22 analysts
$183.00
3.86% Upside
 +10.9% ·
ARDT
Ardent Health Partners, Inc.
 Oct 07, 2026 BUY Buy
+14.5% avg upside
17 analysts
$13.00
8.12% Upside
 +65.2% ·
SLQT
SelectQuote
 Aug 25, 2026 HOLD Buy
+2038.1% avg upside
16 analysts
$3.00
740.42% Upside
 -16.4% ·
EHTH
Ehealth
 Aug 24, 2026 HOLD Buy
+3096.7% avg upside
19 analysts
$2.00
306.34% Upside
 -64.2% ·
AVAH
Aveanna Healthcare Holdings
 Aug 21, 2026 BUY Buy
-13.4% avg upside
19 analysts
$16.00
21.52% Upside
 -12.2% ·
PNTG
Pennant Group
 Aug 19, 2026 BUY Strong Buy
-11.2% avg upside
9 analysts
$44.00
5.62% Upside
 -7.2% ·
SNDA
Sonida Senior Living
 Aug 12, 2026 BUY Buy
+144.2% avg upside
14 analysts
$48.00
40.04% Upside
 -16.1% ·
CON
Concentra Group Holdings Parent, Inc.
 Aug 10, 2026 BUY Strong Buy
+0.7% avg upside
14 analysts
$42.00
3.94% Upside
 +23.8% ·
PACS
PACS Group Inc
 Aug 05, 2026 BUY Strong Buy
+3.3% avg upside
9 analysts
$57.00
19.25% Upside
 +9.7% ·
ADUS
Addus Homecare
 Aug 05, 2026 BUY Strong Buy
+2.4% avg upside
19 analysts
$134.00
6.84% Upside
 +6.2% ·
AHCO
AdaptHealth
 Aug 05, 2026 BUY Strong Buy
+106.2% avg upside
13 analysts
$8.00
37.70% Upside
 +19.3% ·
ACHC
Acadia Healthcare
 Jul 30, 2026 BUY Strong Buy
+49.8% avg upside
18 analysts
$31.00
3.48% Upside
 +36.5% ·
ENSG
The Ensign Group
 Jul 27, 2026 BUY Strong Buy
-6.9% avg upside
9 analysts
$228.00
25.66% Upside
 +6.0% ·
GLPI
Gaming and Leisure
 Jul 25, 2025 BUY Buy
+29.8% avg upside
34 analysts
$53.00
36.03% Upside
 +3.6% ·
EHC
Encompass Health
 Apr 27, 2025 BUY Strong Buy
-11.5% avg upside
23 analysts
$125.00
8.03% Downside
 -11.9% ·
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ben Hendrix — Frequently Asked Questions
How accurate are Ben Hendrix's stock ratings?
Based on the calls 13Foresight could measure, about 58% of Ben's ratings were profitable over a one-year hold, with an average return of +5.0% per rating, or +24.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ben ranked on 13Foresight?
Ben Hendrix is currently ranked #978 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ben cover?
Ben most recently has ratings on HCA, MAX, CHE, SGRY, MOH, ELV, UNH, BKD, CI, CNC, CYH, CVS and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.